Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2− Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in Croatia

• Main Authors: Dora Čerina Pavlinović (Author), Natalija Dedić Plavetić (Author), Ingrid Belac Lovasić (Author), Robert Šeparović (Author), Josipa Flam (Author), Marija Pancirov (Author), Žarko Bajić (Author), Snježana Tomić (Author), Eduard Vrdoljak (Author)
• Format: Book
• Published: Wiley, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction. Disease recurrence in patients with the early hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2−) breast tumor subtype is particularly challenging to manage due to its complex and very heterogeneous biological nature. Namely, due to primary and se...